PAVmed (PAVM) Current Assets (2015 - 2025)
PAVmed's (PAVM) quarterly Current Assets came in at $2.6 million in Q4 2025, up 18.16% year-on-year from $2.2 million in Q4 2024, and down 38.99% quarter-over-quarter from $4.2 million in Q3 2025.
PAVmed (PAVM) Current Assets (2015 - 2025) Analysis & Trends
PAVmed's Current Assets history runs 11 years deep, the most recent figure standing at $2.6 million for Q4 2025.
- On a quarterly basis, Current Assets rose 18.16% year-over-year to $2.6 million in Q4 2025; TTM through Dec 2025 was $2.6 million, a 18.16% increase from a year earlier, with the FY2025 full-year figure at $2.6 million, up 18.16% from the prior year.
- Current Assets retreated to $2.6 million in Q4 2025 per PAVM's latest filing, from $4.2 million in the prior quarter.
- Across five years, Current Assets topped out at $82.6 million in Q4 2021 and bottomed at $2.2 million in Q4 2024.
- The 5-year median for Current Assets is $37.1 million (2021), against an average of $36.0 million.
- Across the five-year window, Current Assets surged 468.26% in 2021 and sank 91.17% in 2024, its largest moves.
- Year by year, Current Assets stood at $82.6 million in 2021, then slumped by 46.84% to $43.9 million in 2022, then plunged by 44.23% to $24.5 million in 2023, then sank by 91.17% to $2.2 million in 2024, then grew by 18.16% to $2.6 million in 2025.
- Per Business Quant, the three latest PAVM Current Assets figures stand at $2.6 million (Q4 2025), $4.2 million (Q3 2025), and $5.5 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 25.51 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 13.34 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 24.79 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 8.68 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 6.23 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 4.33 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 11.45 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.43 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 4.10 Bn |
| 10 | PAVmed | 9.85 Mn | -3.35 Mn | -4,000.00 | 2.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.56 Mn |
| Sep 30, 2025 | 4.19 Mn |
| Jun 30, 2025 | 5.49 Mn |
| Mar 31, 2025 | 3.64 Mn |
| Dec 31, 2024 | 2.16 Mn |
| Sep 10, 2024 | 19.95 Mn |
| Jun 30, 2024 | 30.21 Mn |
| Mar 31, 2024 | 29.57 Mn |
| Dec 31, 2023 | 24.50 Mn |
| Sep 30, 2023 | 32.46 Mn |
| Jun 30, 2023 | 43.13 Mn |
| Mar 31, 2023 | 53.84 Mn |
| Dec 31, 2022 | 43.93 Mn |
| Sep 30, 2022 | 61.98 Mn |
| Jun 30, 2022 | 70.82 Mn |
| Mar 31, 2022 | 71.00 Mn |
| Dec 31, 2021 | 82.64 Mn |
| Sep 30, 2021 | 41.73 Mn |
| Jun 30, 2021 | 46.34 Mn |
| Mar 31, 2021 | 50.51 Mn |